Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Autologous

Allogeneic, unrelated

Allogeneic, related

Bone marrow

PBSC

Single cord blood unit

Multiple cord blood units

Other product

Specify:

Donor/Cord Blood Unit Identification Questions: 1 - 12

Specify the person for whom this typing is being done1

Non-NMDP unrelated donor ID:2 (not applicable for related donor)

Non-NMDP cord blood unit ID:3 (include related and autologous CBUs)

Is the cord blood unit maternal HLA typing available?4

yes -Complete form 2005 to report cord blood unit maternal HLA typing

no

Specify recipient’s biological relative and typing5

Specify other biological relative and typing:6

Date of birth

Known Unknown

7

(donor/infant)

Date of birth:8 __ __ __ __ - __ __- __ __

(donor/infant)

Age

Known Unknown

9

(donor/infant)

Age:10

(donor/infant)

Months (use if less than 1 year old)

years

Sex

male female

11

(donor/infant)

Was the person for whom this typing is being done used as the donor?

yes no

12

HLA Typing by DNA Technology Questions: 13 - 35

Was documentation submitted to the CIBMTR?

Yes No

13

Locus A

Known Unknown

14

First A* allele designations:15 Second A* allele designations:

Locus B

Known Unknown

16

First B* allele designations:17 Second B* allele designations:

Locus C

Known Unknown

18

First C* allele designations:19 Second C* allele designations:

Locus DRB1

Known Unknown

20

First DRB1* allele designations:21 Second DRB1* allele designations:

Locus DRB3

Known Unknown

22

First DRB3* allele designations:23 Second DRB3* allele designations:

Locus DRB4

Known Unknown

24

First DRB4* allele designations:25 Second DRB4* allele designations:

Locus DRB5

Known Unknown

26

First DRB5* allele designations:27 Second DRB5* allele designations:

Locus DQB1

Known Unknown

28

First DQB1* allele designations:29 Second DQB1* allele designations:

Locus DPB1

Known Unknown

30

First DPB1* allele designations:31 Second DPB1* allele designations:

Locus DQA1

Known Unknown

32

First DQA1* allele designations:33 Second DQA1* allele designations:

Locus DPA1

Known Unknown

34

First DPA1* allele designations:35 Second DPA1* allele designations:

Antigens Defined by Serologic Typing Questions: 36 - 41

Number of antigens provided

one two

36

Specificity – 1st antigen37

Specificity – 2nd antigen38

Number of antigens provided

one two

39

Specificity – 1st antigen40

Specificity – 2nd antigen41

Optional Antigen Reporting Questions: 42 - 58

Number of antigens provided

one two

42

Specificity – 1st antigen43

Specificity – 2nd antigen44

Specificity Bw4 present?

yes no

45

Specificity Bw6 present?

yes no

46

Number of antigens provided

one two

47

Specificity – 1st antigen48

Specificity – 2nd antigen49

Specificity DR51 present?

yes no

50

Specificity DR52 present?

yes no

51

Specificity DR53 present?

yes no

52

Number of antigens provided

one two

53

Specificity – 1st antigen54

Specificity – 2nd antigen55

Number of antigens provided

one two

56

Specificity – 1st antigen57

Specificity – 2nd antigen58

First Name:

Last Name:

E-mail address:

Date: __ __ __ __ - __ __- __ __

OMB No: 0915-0310

Expiration Date: 1/31/2020

Public Burden Statement:  An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control
number.  The OMB control number for this project is 0915-0310.  Public reporting burden for this collection of information is estimated to average 1.0 hours per response, including the
time for reviewing instructions, searching existing data sources, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other
aspect of this collection of information, including suggestions for reducing this burden, to HRSA Reports Clearance Officer, 5600 Fishers Lane, Room 10-29, Rockville, Maryland, 20857.

HCT type: (check all that apply)

Product type: (check all that apply)

This form must be completed for all non-NMDP allogeneic or syngeneic donors or recipients, or non-NMDP cord blood units.  If the donor, recipient, or cord blood unit was secured
through the NMDP, then report HLA typing on the appropriate NMDP forms. 

A separate copy of this form should be completed for each non-NMDP donor, recipient, or cord blood unit.  Parental typing (maternal and paternal) should be submitted for all
mismatched related donor transplants (CRF track only), if available.  Cord blood maternal typing should be submitted for all unrelated cord blood transplants (CRF track only), if
available.

HLA Alleles Defined by DNA Technology (e.g., Sequence Specific Oligonucleotide Probe (SSOP) typing, Sequence Specific Primer (SSP) typing or Sequence Based (SBT) typing.)
DNA technology can be used to type for a single allele, combinations of alleles (allele strings) or a “generic” allele designation which is similar to a serologic typing result. For this
reason, the number of digits, as well as the number of alleles, for reporting will vary.
Laboratories may use “ / ” , “ – ” or a combination of numbers and letters on the typing report as a shorthand notation for the results. Transcribe the information onto the form as directly
as possible. The letters are called allele codes, and will be 1 or more characters in length which represent a combination of possible alleles at a locus. The same allele combination
may be reported several different ways (e.g., DRB1*01:01 or 01:02, DRB1*01:01/01:02, DRB1*01:01/02, or DRB1*01:AB).
There will be two alleles reported for each locus, unless the individual is presumed homozygous (i.e., carries two copies of the same allele) at a locus. Transcribe the first allele
designation in the first box, and the second allele designation in the second box. If the person is homozygous, leave the second box blank.

Class I

Class II

Class II (Optional)

Please provide the optional allele information if it is available from your laboratory.

Use the following lists when reporting HLA-A and B antigens. Report broad antigens only when your laboratory was not able to confirm typing for a known split antigen.

Instructions for the use of the “X” Antigen Specificity for Typing By Serology

Each HLA locus has a serologically defined “X” antigen specificity: AX, BX, CX, DRX, DPX, and DQX. At this time an “X” specificity is defined as “unknown but known to be different from
the other antigen at that locus.” This is different from a blank specificity, which is defined as “unknown but assumed to be the same as the other antigen at that locus.” When
comparisons between recipient and donor antigens involve an “X” or “blank” specificity, the “X” or “blank” is assumed to be homozygous for the antigen reported at the locus. In other
words, the search algorithm treats typings containing “blank” or “X” antigens in the same manner as known homozygous typings.

A Antigens

B Antigens

Please provide the following optional antigen information if it is available from your laboratory.

Antigens Defined by Serologic Typing

C Antigens

Bw Specificity

DR Antigens

DR51 Specificity

DR52 Antigen

DR53 Antigen

DQ Antigens

DP Antigens

Center: CRID: 

Form 2005 R6.0: Confirmation of HLA Typing

CIBMTR Form 2005 revision 6.0 last updated January 2017 
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 1 / 3



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Autologous

Allogeneic, unrelated

Allogeneic, related

Bone marrow

PBSC

Single cord blood unit

Multiple cord blood units

Other product

Specify:

Donor/Cord Blood Unit Identification Questions: 1 - 12

Specify the person for whom this typing is being done1

Non-NMDP unrelated donor ID:2 (not applicable for related donor)

Non-NMDP cord blood unit ID:3 (include related and autologous CBUs)

Is the cord blood unit maternal HLA typing available?4

yes -Complete form 2005 to report cord blood unit maternal HLA typing

no

Specify recipient’s biological relative and typing5

Specify other biological relative and typing:6

Date of birth

Known Unknown

7

(donor/infant)

Date of birth:8 __ __ __ __ - __ __- __ __

(donor/infant)

Age

Known Unknown

9

(donor/infant)

Age:10

(donor/infant)

Months (use if less than 1 year old)

years

Sex

male female

11

(donor/infant)

Was the person for whom this typing is being done used as the donor?

yes no

12

HLA Typing by DNA Technology Questions: 13 - 35

Was documentation submitted to the CIBMTR?

Yes No

13

Locus A

Known Unknown

14

First A* allele designations:15 Second A* allele designations:

Locus B

Known Unknown

16

First B* allele designations:17 Second B* allele designations:

Locus C

Known Unknown

18

First C* allele designations:19 Second C* allele designations:

Locus DRB1

Known Unknown

20

First DRB1* allele designations:21 Second DRB1* allele designations:

Locus DRB3

Known Unknown

22

First DRB3* allele designations:23 Second DRB3* allele designations:

Locus DRB4

Known Unknown

24

First DRB4* allele designations:25 Second DRB4* allele designations:

Locus DRB5

Known Unknown

26

First DRB5* allele designations:27 Second DRB5* allele designations:

Locus DQB1

Known Unknown

28

First DQB1* allele designations:29 Second DQB1* allele designations:

Locus DPB1

Known Unknown

30

First DPB1* allele designations:31 Second DPB1* allele designations:

Locus DQA1

Known Unknown

32

First DQA1* allele designations:33 Second DQA1* allele designations:

Locus DPA1

Known Unknown

34

First DPA1* allele designations:35 Second DPA1* allele designations:

Antigens Defined by Serologic Typing Questions: 36 - 41

Number of antigens provided

one two

36

Specificity – 1st antigen37

Specificity – 2nd antigen38

Number of antigens provided

one two

39

Specificity – 1st antigen40

Specificity – 2nd antigen41

Optional Antigen Reporting Questions: 42 - 58

Number of antigens provided

one two

42

Specificity – 1st antigen43

Specificity – 2nd antigen44

Specificity Bw4 present?

yes no

45

Specificity Bw6 present?

yes no

46

Number of antigens provided

one two

47

Specificity – 1st antigen48

Specificity – 2nd antigen49

Specificity DR51 present?

yes no

50

Specificity DR52 present?

yes no

51

Specificity DR53 present?

yes no

52

Number of antigens provided

one two

53

Specificity – 1st antigen54

Specificity – 2nd antigen55

Number of antigens provided

one two

56

Specificity – 1st antigen57

Specificity – 2nd antigen58

First Name:

Last Name:

E-mail address:

Date: __ __ __ __ - __ __- __ __

OMB No: 0915-0310

Expiration Date: 1/31/2020

Public Burden Statement:  An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control
number.  The OMB control number for this project is 0915-0310.  Public reporting burden for this collection of information is estimated to average 1.0 hours per response, including the
time for reviewing instructions, searching existing data sources, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other
aspect of this collection of information, including suggestions for reducing this burden, to HRSA Reports Clearance Officer, 5600 Fishers Lane, Room 10-29, Rockville, Maryland, 20857.

HCT type: (check all that apply)

Product type: (check all that apply)

This form must be completed for all non-NMDP allogeneic or syngeneic donors or recipients, or non-NMDP cord blood units.  If the donor, recipient, or cord blood unit was secured
through the NMDP, then report HLA typing on the appropriate NMDP forms. 

A separate copy of this form should be completed for each non-NMDP donor, recipient, or cord blood unit.  Parental typing (maternal and paternal) should be submitted for all
mismatched related donor transplants (CRF track only), if available.  Cord blood maternal typing should be submitted for all unrelated cord blood transplants (CRF track only), if
available.

HLA Alleles Defined by DNA Technology (e.g., Sequence Specific Oligonucleotide Probe (SSOP) typing, Sequence Specific Primer (SSP) typing or Sequence Based (SBT) typing.)
DNA technology can be used to type for a single allele, combinations of alleles (allele strings) or a “generic” allele designation which is similar to a serologic typing result. For this
reason, the number of digits, as well as the number of alleles, for reporting will vary.
Laboratories may use “ / ” , “ – ” or a combination of numbers and letters on the typing report as a shorthand notation for the results. Transcribe the information onto the form as directly
as possible. The letters are called allele codes, and will be 1 or more characters in length which represent a combination of possible alleles at a locus. The same allele combination
may be reported several different ways (e.g., DRB1*01:01 or 01:02, DRB1*01:01/01:02, DRB1*01:01/02, or DRB1*01:AB).
There will be two alleles reported for each locus, unless the individual is presumed homozygous (i.e., carries two copies of the same allele) at a locus. Transcribe the first allele
designation in the first box, and the second allele designation in the second box. If the person is homozygous, leave the second box blank.

Class I

Class II

Class II (Optional)

Please provide the optional allele information if it is available from your laboratory.

Use the following lists when reporting HLA-A and B antigens. Report broad antigens only when your laboratory was not able to confirm typing for a known split antigen.

Instructions for the use of the “X” Antigen Specificity for Typing By Serology

Each HLA locus has a serologically defined “X” antigen specificity: AX, BX, CX, DRX, DPX, and DQX. At this time an “X” specificity is defined as “unknown but known to be different from
the other antigen at that locus.” This is different from a blank specificity, which is defined as “unknown but assumed to be the same as the other antigen at that locus.” When
comparisons between recipient and donor antigens involve an “X” or “blank” specificity, the “X” or “blank” is assumed to be homozygous for the antigen reported at the locus. In other
words, the search algorithm treats typings containing “blank” or “X” antigens in the same manner as known homozygous typings.

A Antigens

B Antigens

Please provide the following optional antigen information if it is available from your laboratory.

Antigens Defined by Serologic Typing

C Antigens

Bw Specificity

DR Antigens

DR51 Specificity

DR52 Antigen

DR53 Antigen

DQ Antigens

DP Antigens

Center: CRID: 

Form 2005 R6.0: Confirmation of HLA Typing

CIBMTR Form 2005 revision 6.0 last updated January 2017 
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 2 / 3



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Autologous

Allogeneic, unrelated

Allogeneic, related

Bone marrow

PBSC

Single cord blood unit

Multiple cord blood units

Other product

Specify:

Donor/Cord Blood Unit Identification Questions: 1 - 12

Specify the person for whom this typing is being done1

Non-NMDP unrelated donor ID:2 (not applicable for related donor)

Non-NMDP cord blood unit ID:3 (include related and autologous CBUs)

Is the cord blood unit maternal HLA typing available?4

yes -Complete form 2005 to report cord blood unit maternal HLA typing

no

Specify recipient’s biological relative and typing5

Specify other biological relative and typing:6

Date of birth

Known Unknown

7

(donor/infant)

Date of birth:8 __ __ __ __ - __ __- __ __

(donor/infant)

Age

Known Unknown

9

(donor/infant)

Age:10

(donor/infant)

Months (use if less than 1 year old)

years

Sex

male female

11

(donor/infant)

Was the person for whom this typing is being done used as the donor?

yes no

12

HLA Typing by DNA Technology Questions: 13 - 35

Was documentation submitted to the CIBMTR?

Yes No

13

Locus A

Known Unknown

14

First A* allele designations:15 Second A* allele designations:

Locus B

Known Unknown

16

First B* allele designations:17 Second B* allele designations:

Locus C

Known Unknown

18

First C* allele designations:19 Second C* allele designations:

Locus DRB1

Known Unknown

20

First DRB1* allele designations:21 Second DRB1* allele designations:

Locus DRB3

Known Unknown

22

First DRB3* allele designations:23 Second DRB3* allele designations:

Locus DRB4

Known Unknown

24

First DRB4* allele designations:25 Second DRB4* allele designations:

Locus DRB5

Known Unknown

26

First DRB5* allele designations:27 Second DRB5* allele designations:

Locus DQB1

Known Unknown

28

First DQB1* allele designations:29 Second DQB1* allele designations:

Locus DPB1

Known Unknown

30

First DPB1* allele designations:31 Second DPB1* allele designations:

Locus DQA1

Known Unknown

32

First DQA1* allele designations:33 Second DQA1* allele designations:

Locus DPA1

Known Unknown

34

First DPA1* allele designations:35 Second DPA1* allele designations:

Antigens Defined by Serologic Typing Questions: 36 - 41

Number of antigens provided

one two

36

Specificity – 1st antigen37

Specificity – 2nd antigen38

Number of antigens provided

one two

39

Specificity – 1st antigen40

Specificity – 2nd antigen41

Optional Antigen Reporting Questions: 42 - 58

Number of antigens provided

one two

42

Specificity – 1st antigen43

Specificity – 2nd antigen44

Specificity Bw4 present?

yes no

45

Specificity Bw6 present?

yes no

46

Number of antigens provided

one two

47

Specificity – 1st antigen48

Specificity – 2nd antigen49

Specificity DR51 present?

yes no

50

Specificity DR52 present?

yes no

51

Specificity DR53 present?

yes no

52

Number of antigens provided

one two

53

Specificity – 1st antigen54

Specificity – 2nd antigen55

Number of antigens provided

one two

56

Specificity – 1st antigen57

Specificity – 2nd antigen58

First Name:

Last Name:

E-mail address:

Date: __ __ __ __ - __ __- __ __

OMB No: 0915-0310

Expiration Date: 1/31/2020

Public Burden Statement:  An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control
number.  The OMB control number for this project is 0915-0310.  Public reporting burden for this collection of information is estimated to average 1.0 hours per response, including the
time for reviewing instructions, searching existing data sources, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other
aspect of this collection of information, including suggestions for reducing this burden, to HRSA Reports Clearance Officer, 5600 Fishers Lane, Room 10-29, Rockville, Maryland, 20857.

HCT type: (check all that apply)

Product type: (check all that apply)

This form must be completed for all non-NMDP allogeneic or syngeneic donors or recipients, or non-NMDP cord blood units.  If the donor, recipient, or cord blood unit was secured
through the NMDP, then report HLA typing on the appropriate NMDP forms. 

A separate copy of this form should be completed for each non-NMDP donor, recipient, or cord blood unit.  Parental typing (maternal and paternal) should be submitted for all
mismatched related donor transplants (CRF track only), if available.  Cord blood maternal typing should be submitted for all unrelated cord blood transplants (CRF track only), if
available.

HLA Alleles Defined by DNA Technology (e.g., Sequence Specific Oligonucleotide Probe (SSOP) typing, Sequence Specific Primer (SSP) typing or Sequence Based (SBT) typing.)
DNA technology can be used to type for a single allele, combinations of alleles (allele strings) or a “generic” allele designation which is similar to a serologic typing result. For this
reason, the number of digits, as well as the number of alleles, for reporting will vary.
Laboratories may use “ / ” , “ – ” or a combination of numbers and letters on the typing report as a shorthand notation for the results. Transcribe the information onto the form as directly
as possible. The letters are called allele codes, and will be 1 or more characters in length which represent a combination of possible alleles at a locus. The same allele combination
may be reported several different ways (e.g., DRB1*01:01 or 01:02, DRB1*01:01/01:02, DRB1*01:01/02, or DRB1*01:AB).
There will be two alleles reported for each locus, unless the individual is presumed homozygous (i.e., carries two copies of the same allele) at a locus. Transcribe the first allele
designation in the first box, and the second allele designation in the second box. If the person is homozygous, leave the second box blank.

Class I

Class II

Class II (Optional)

Please provide the optional allele information if it is available from your laboratory.

Use the following lists when reporting HLA-A and B antigens. Report broad antigens only when your laboratory was not able to confirm typing for a known split antigen.

Instructions for the use of the “X” Antigen Specificity for Typing By Serology

Each HLA locus has a serologically defined “X” antigen specificity: AX, BX, CX, DRX, DPX, and DQX. At this time an “X” specificity is defined as “unknown but known to be different from
the other antigen at that locus.” This is different from a blank specificity, which is defined as “unknown but assumed to be the same as the other antigen at that locus.” When
comparisons between recipient and donor antigens involve an “X” or “blank” specificity, the “X” or “blank” is assumed to be homozygous for the antigen reported at the locus. In other
words, the search algorithm treats typings containing “blank” or “X” antigens in the same manner as known homozygous typings.

A Antigens

B Antigens

Please provide the following optional antigen information if it is available from your laboratory.

Antigens Defined by Serologic Typing

C Antigens

Bw Specificity

DR Antigens

DR51 Specificity

DR52 Antigen

DR53 Antigen

DQ Antigens

DP Antigens

Center: CRID: 

Form 2005 R6.0: Confirmation of HLA Typing

CIBMTR Form 2005 revision 6.0 last updated January 2017 
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 3 / 3